Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Der Pathologe
|
August 21, 2002
[Differentiated papillary kidney tumors. Differentiation between metanephric adenoma and papillary adenoma]
A Lugli, F Stoffe, L Terracciano, et al.
British Journal of Cancer
|
May 2, 2013
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
V H Koelzer, E Karamitopoulou, H Dawson, et al.
Microbial Genomics
|
April 20, 2022
Dairy streptococcal cell wall and exopolysaccharide genome diversity
Elvina Parlindungan, Brian McDonnell, Gabriele A Lugli, et al.
British Journal of Cancer
|
November 6, 2008
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
I Zlobec, K Baker, L Terracciano, et al.
Frontiers in Microbiology
|
April 26, 2019
The <i>Lactococcus lactis</i> Pan-Plasmidome
Philip Kelleher, Jennifer Mahony, Francesca Bottacini, et al.
Journal of Clinical Pathology
|
July 4, 2006
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status
A Lugli, I Zlobec, K Baker, et al.
British Journal of Cancer
|
May 20, 2015
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J A Galván, I Zlobec, M Wartenberg, et al.
Journal of Clinical Pathology
|
September 30, 2003
Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases
A Tzankov, A-C Pehrs, A Zimpfer, et al.
British Journal of Cancer
|
February 13, 2025
Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J A Galván, I Zlobec, M Wartenberg, et al.
Gut
|
April 26, 2008
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
I Zlobec, L Terracciano, L Tornillo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Der Pathologe
|
August 21, 2002
[Differentiated papillary kidney tumors. Differentiation between metanephric adenoma and papillary adenoma]
A Lugli, F Stoffe, L Terracciano, et al.
British Journal of Cancer
|
May 2, 2013
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
V H Koelzer, E Karamitopoulou, H Dawson, et al.
Microbial Genomics
|
April 20, 2022
Dairy streptococcal cell wall and exopolysaccharide genome diversity
Elvina Parlindungan, Brian McDonnell, Gabriele A Lugli, et al.
British Journal of Cancer
|
November 6, 2008
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
I Zlobec, K Baker, L Terracciano, et al.
Frontiers in Microbiology
|
April 26, 2019
The <i>Lactococcus lactis</i> Pan-Plasmidome
Philip Kelleher, Jennifer Mahony, Francesca Bottacini, et al.
Journal of Clinical Pathology
|
July 4, 2006
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status
A Lugli, I Zlobec, K Baker, et al.
British Journal of Cancer
|
May 20, 2015
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J A Galván, I Zlobec, M Wartenberg, et al.
Journal of Clinical Pathology
|
September 30, 2003
Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases
A Tzankov, A-C Pehrs, A Zimpfer, et al.
British Journal of Cancer
|
February 13, 2025
Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J A Galván, I Zlobec, M Wartenberg, et al.
Gut
|
April 26, 2008
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
I Zlobec, L Terracciano, L Tornillo, et al.
Page
of 7